Sanofi
April 1, 2022 11:23 AM EDT
Pharma
Manufacturing

Sanofi's plan to list its API spin­out in France is a go

Josh Sullivan

Sanofi’s plan to list its API spin­off on the French mar­kets has been ap­proved, and trad­ing will start on May 6, the com­pa­ny

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Phar­ma is next in line as Trump says tar­iffs are com­ing 'very short­ly'

Phar­ma CEOs warn EU of po­ten­tial ‘ex­o­dus to the US’ as trade war con­tin­ues

Could Kennedy's FDA cuts trig­ger an ob­scure claw­back pro­vi­sion for in­dus­try user fees?

Q&A: Lund­beck’s head of R&D on let­ting ‘bi­ol­o­gy speak’ in neu­ro­science

Amid Trump’s re­search cuts, com­mis­sion says US risks los­ing biotech race with­out $15B in­vest­ment

Ex­clu­sive: Meri­da Bio­sciences gets $121M to treat au­toim­mune and al­ler­gy dis­eases at their roots

A service from the Financial Times